CDC to discuss reports of heart inflammation in young people after COVID vaccines
CDC meeting on possible link between vaccines and rare cases of heart inflammation
Replay Video UP NEXT A CDC advisory panel is set to convene in an emergency meeting next week to discuss reports of heart inflammation in adolescents who received the COVID-19 vaccine. CDC says 226 confirmed cases of the condition, called myocarditis, have been reported in people under 30 who received the Pfizer or Moderna COVID-19 vaccines. Myocarditis tends to be temporary and clears up with treatment and monitoring, but the CDC is analyzing these cases to see if there s a link to vaccination.MORE: FDA authorizes Pfizer vaccine for 12-15-year-olds
Federal health officials are investigating whether the unusually high number of reports of heart inflammation in teens and young adults is tied to vaccinations for COVID-19, particularly after the second dose of a messenger-RNA version from Pfizer and Moderna.
A higher-than-expected number of young men have experienced heart inflammation after their second dose of the mRNA COVID-19 shots from Pfizer/BioNTech and Moderna, according to data from two vaccine safety monitoring systems, the U.S. Centers for Disease Control and Prevention (CDC) said on Thursday.
Heart Inflammation From Pfizer, Moderna COVID-19 Vaccines Higher Than Expected: CDC
KEY POINTS
Scientists expected between 10 to 102 cases of heart inflammation in 16- to 24-year-olds
The CDC said there were 475 cases of heart inflammation among people aged 30 and younger
The agency will convene an emergency meeting on June 18
Preliminary data show higher-than-expected rates of heart inflammation among younger adults who received their second shot of COVID-19 vaccine from Pfizer/BioNTech or Moderna, the U.S. Centers for Disease Control and Prevention said.
The agency Thursday revealed that its vaccine safety monitor system received 275 reports of myocarditis or pericarditis in 16- to 24-year-olds who received their final dose of the COVID-19 vaccine, as of May 31.